Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 1Obesity 1

Interventions

Tirzepatide 3naldemedine 1mirabegron 1ma zi ren wan 1exemestane 1Transcutaneous Electric Nerve Stimulation 1Tablets 1Specimen Handling 1Resistance Training 1Metformin 1Megestrol Acetate 1Leuprolide 1Letrozole 1Hypnosis 1Hydroquinones 1Goserelin 1Gonadotropin-Releasing Hormone 1Educational Status 1Cryotherapy 1Counseling 1Caloric Restriction 1Bupropion 1Ascorbic Acid 1Aromatase Inhibitors 1Anastrozole 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
mirabegron × Other × 30 days × Clear all
NCT03049462 2026-06-01

The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
100 enrolled
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡